Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2012 | 1 |
2014 | 1 |
2015 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 1 Pleural Hemorrhage, CTCAE"
Page 1
Complications after 100 sessions of cone-beam computed tomography-guided lung radiofrequency ablation: a single-center, retrospective experience.
Int J Hyperthermia. 2020;37(1):763-771. doi: 10.1080/02656736.2020.1784472.
Int J Hyperthermia. 2020.
PMID: 32619365
Free article.
Complications were recorded using the Common Terminology Criteria of Adverse Events (CTCAE) 5.0. A major complication was defined as a grade 3 or 4 adverse event.Results: There was no postprocedural mortality. The major and minor complication rates were 5% and 28%, …
Complications were recorded using the Common Terminology Criteria of Adverse Events (CTCAE) 5.0. A major complication was defined as …
Percutaneous cryoablation for inoperable malignant lung tumors: midterm results.
Chou HP, Chen CK, Shen SH, Sheu MH, Wu MH, Wu YC, Chang CY.
Chou HP, et al.
Cryobiology. 2015 Feb;70(1):60-5. doi: 10.1016/j.cryobiol.2014.12.004. Epub 2014 Dec 23.
Cryobiology. 2015.
PMID: 25541142
RESULTS: The immediate during and short-term complications with CTCAE grade 2 or upper include pneumothorax (15%), pleural effusion (20%), pulmonary hemorrhage (24%), pneumonitis (15%), hemothorax (15%), hemoptysis (10%), pain (20%), bronchopleu …
RESULTS: The immediate during and short-term complications with CTCAE grade 2 or upper include pneumothorax (15%), pleural …
Item in Clipboard
Active Versus Passive Thaw After Percutaneous Cryoablation of Pulmonary Tumors: Effect on Incidence, Grade, and Onset of Hemoptysis.
Wrobel MM, Bourgouin PP, Abrishami Kashani M, Leppelmann KS, Vazquez R, Pachamanova DA, Fintelmann FJ.
Wrobel MM, et al.
AJR Am J Roentgenol. 2021 Nov;217(5):1153-1163. doi: 10.2214/AJR.21.25872. Epub 2021 May 19.
AJR Am J Roentgenol. 2021.
PMID: 34008999
The incidence, onset, and management of hemoptysis were recorded using prospectively collected data. Hemoptysis, pneumothorax, and hemothorax within 30 days after ablation were graded according to Common Terminology Criteria for Adverse Events (CTCAE) version …
The incidence, onset, and management of hemoptysis were recorded using prospectively collected data. Hemoptysis, pneumothorax, and hemoth …
Item in Clipboard
Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas.
Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C.
Fields EC, et al.
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):51-7. doi: 10.1016/j.ijrobp.2010.09.008. Epub 2010 Oct 29.
Int J Radiat Oncol Biol Phys. 2012.
PMID: 21035955
Clinical Trial.
The MTD was defined as the dose of vandetanib at which less than 33% of patients developed DLTs, defined by the Common Terminology Criteria for Adverse Events (CTCAE) version 3 as any Grade 3 or greater nonhematologic toxicity and Grade 4 or greater hematolog …
The MTD was defined as the dose of vandetanib at which less than 33% of patients developed DLTs, defined by the Common Terminology Criteria …
Item in Clipboard
Cite
Cite